updated 12/28/2010 6:45:23 AM ET 2010-12-28T11:45:23

STEVENSON, Wash., Dec. 28, 2010 (GLOBE NEWSWIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that TNS has entered into an exclusive Product Development and Distribution Agreement with Koch International (Koch), Seoul, Korea, for TNS dietary supplements. Koch has agreed to develop the TNS brand of nutraceutical products throughout Korea through its expertise and experience in internet marketing, radio, TV and newspaper networks and contacts in the ever-expanding consumer health care product market.

Koch intends to move aggressively to establish the TNS premier line of health care products in the growing Korean consumer dietary supplement market. Consumers in Korea, despite the economic downturn, continue to purchase over-the-counter preventative natural dietary supplements. Koch and TNS have engaged E-ZRA, Seoul, Korea, to register TNS products as functional foods with the Korea Food and Drug Administration (KFDA). E-ZRA has a 20-year history in Foods and Supplements Product regulatory matters and will perform product registration and consulting services.

Mr. Suk Whan Chang, a successful entrepreneur with expertise in finance and investments, is a principal and founder of Koch, a graduate of the Massachusetts Institute of Technology (MIT) and The Sloan School of Management.

Chang states, "We are extremely excited about the opportunity to introduce and distribute natural organic mushroom-based dietary supplements to a growing population of health conscious Korean consumers. Our networks of sales and marketing partners are keen to help distribute these products throughout Korea."

"The Korean distribution agreement represents a significant event in the TNS aggressive growth strategy as our company moves our portfolio of health care products into international markets," stated Marvin S. Hausman MD, CEO, TNS. "We believe that the TNS-Koch partnership will lead to increased sales and revenues for both companies."

About Total Nutraceutical Solutions, Inc.:

TNS, a global biotechnology leader in whole food mushroom research and development, focuses on discovering, formulating and marketing products composed primarily of organic natural whole mushroom foods, containing bioactive nutrients, such as L-Ergothioneine and Vitamin D, with potential health benefits. Our scientific strategy is to specialize in the development of production and analytic technologies for food and nutritional supplements mainly composed of mushrooms and their mycelial biomasses. Novel clinical models and biomarkers are used to show nutritional and clinical efficacy of our products. In addition to our novel preventative health care formulations and nutritional approaches for a wide variety of human conditions and illnesses, we are also involved in the development, acquisition and ownership of breakthrough nutritional tools and products in the fields of animal husbandry and livestock feeds.

The Total Nutraceutical Solutions, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8060

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the
transactiondescribed in this press release, and other risks identified in the filings by Total Nutraceutical Solutions (TNS), Inc., with the Securities and Exchange Commission. Further information on risks faced by TNS are detailed in the Form 10-K for the year ended December 31, 2009, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the Securities and Exchange Commission at http ://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. TNS does not undertake any obligation to publicly release the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

CONTACT:  Total Nutraceutical Solutions, Inc.
          Roberta Matta
          509-427-5132
          www.totalnutraceutical.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.91%
$30K home equity loan FICO 5.20%
$75K home equity loan FICO 4.57%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.42%
13.40%
Cash Back Cards 17.92%
17.92%
Rewards Cards 17.13%
17.12%
Source: Bankrate.com